Holdings of Select Biotechnology Portfolio
Fidelity Select Portfolios ·161 declared positions · as of Feb 28, 2026
Original filing · Net assets 5.4B $ · Ten largest lines: 55.1 % of the equity sleeve
Sector breakdown
- Health care 47.5 %
- Industrials 0.7 %
- Unattributed 51.7 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 95.9 %
- EUR 2.4 %
- CHF 0.9 %
- DKK 0.8 %
- SEK 0.1 %
The quoted currency of each line, as declared.
Country breakdown
- US 87.5 %
- DK 3.3 %
- NL 2.8 %
- BE 2.2 %
- BM 1.1 %
- CH 0.9 %
- FR 0.8 %
- VG 0.4 %
- CA 0.3 %
- IE 0.2 %
- DE 0.2 %
- SG 0.1 %
- Other countries 0.2 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 135 | 4.6B $ | 87.48 % |
| 2 | DK | 3 | 173.2M $ | 3.29 % |
| 3 | NL | 4 | 148.8M $ | 2.83 % |
| 4 | BE | 1 | 116.3M $ | 2.21 % |
| 5 | BM | 1 | 57.1M $ | 1.09 % |
| 6 | CH | 2 | 45.9M $ | 0.87 % |
| 7 | FR | 2 | 44.4M $ | 0.84 % |
| 8 | VG | 1 | 18.5M $ | 0.35 % |
| 9 | CA | 2 | 15.2M $ | 0.29 % |
| 10 | IE | 3 | 11.8M $ | 0.22 % |
| 11 | DE | 1 | 9.4M $ | 0.18 % |
| 12 | SG | 1 | 6.8M $ | 0.13 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 101 | Design Therapeutics Inc | 616,831 | 6.4M $ | 0.12 % |
| 102 | Nurix Therapeutics Inc | 396,646 | 6.3M $ | 0.12 % |
| 103 | CAMP4 THERAPEUTICS CORP | 1,326,208 | 6M $ | 0.11 % |
| 104 | X4 PHARMACEUTICALS INC | 1,685,700 | 5.8M $ | 0.11 % |
| 105 | Prothena Corp PLC | 643,917 | 5.6M $ | 0.10 % |
| 106 | Alector Inc | 2,221,104 | 5.4M $ | 0.10 % |
| 107 | LB Pharmaceuticals Inc | 221,731 | 5.3M $ | 0.10 % |
| 108 | Sana Biotechnology Inc | 1,263,152 | 5.3M $ | 0.10 % |
| 109 | Jazz Pharmaceuticals PLC | 25,600 | 4.9M $ | 0.09 % |
| 110 | JADE BIOSCIENCES INC | 321,707 | 4.8M $ | 0.09 % |
| 111 | Vera Therapeutics Inc | 109,013 | 4.4M $ | 0.08 % |
| 112 | Hansa Biopharma AB | 1,176,800 | 4.4M $ | 0.08 % |
| 113 | Denali Therapeutics Inc | 205,263 | 4.3M $ | 0.08 % |
| 114 | Taysha Gene Therapies Inc | 940,476 | 4.3M $ | 0.08 % |
| 115 | Absci Corp | 1,540,796 | 4.2M $ | 0.08 % |
| 116 | Eikon Therapeutics Inc | 305,088 | 4.2M $ | 0.08 % |
| 117 | Pharvaris NV | 147,914 | 4.2M $ | 0.08 % |
| 118 | Allogene Therapeutics Inc | 1,401,115 | 3.9M $ | 0.07 % |
| 119 | Foghorn Therapeutics Inc | 654,278 | 3.7M $ | 0.07 % |
| 120 | Soleno Therapeutics Inc | 87,300 | 3.4M $ | 0.06 % |
| 121 | Zura Bio Ltd | 509,657 | 3.4M $ | 0.06 % |
| 122 | ARS Pharmaceuticals Inc | 335,156 | 3.1M $ | 0.06 % |
| 123 | Janux Therapeutics Inc | 206,670 | 2.8M $ | 0.05 % |
| 124 | Cartesian Therapeutics Inc | 366,554 | 2.8M $ | 0.05 % |
| 125 | MoonLake Immunotherapeutics | 143,558 | 2.5M $ | 0.05 % |
| 126 | BridgeBio Oncology Therapeutics Inc | 240,300 | 2.4M $ | 0.05 % |
| 127 | ENGENE HOLDINGS INC | 232,200 | 2.3M $ | 0.04 % |
| 128 | Palvella Therapeutics Inc | 16,700 | 2.3M $ | 0.04 % |
| 129 | TG Therapeutics Inc | 66,231 | 2M $ | 0.04 % |
| 130 | Mirum Pharmaceuticals Inc | 20,400 | 1.9M $ | 0.04 % |
| 131 | Upstream Bio Inc | 234,657 | 1.8M $ | 0.03 % |
| 132 | Exelixis Inc | 40,610 | 1.8M $ | 0.03 % |
| 133 | aTyr Pharma Inc | 1,754,594 | 1.7M $ | 0.03 % |
| 134 | CARTESIAN THERAPEUTICS INC | 5,385,728 | 1.6M $ | 0.03 % |
| 135 | Shattuck Labs Inc | 391,662 | 1.5M $ | 0.03 % |
| 136 | Perspective Therapeutics Inc | 258,600 | 1.4M $ | 0.03 % |
| 137 | GH RESEARCH PLC | 92,500 | 1.4M $ | 0.03 % |
| 138 | CRESCENT BIOPHARMA INC | 113,421 | 1.4M $ | 0.03 % |
| 139 | CG oncology Inc | 22,628 | 1.3M $ | 0.02 % |
| 140 | AnaptysBio Inc | 23,300 | 1.3M $ | 0.02 % |
| 141 | Neurogene Inc | 51,100 | 1.2M $ | 0.02 % |
| 142 | Day One Biopharmaceuticals Inc | 108,347 | 1.1M $ | 0.02 % |
| 143 | Atea Pharmaceuticals Inc | 237,534 | 1.1M $ | 0.02 % |
| 144 | VeraDermics Inc | 20,800 | 953.7K $ | 0.02 % |
| 145 | LEXICON PHARMACEUTICALS INC | 515,300 | 757.5K $ | 0.01 % |
| 146 | LEGEND BIOTECH CORP | 32,710 | 621.5K $ | 0.01 % |
| 147 | BIOMEA FUSION INC | 452,663 | 620.1K $ | 0.01 % |
| 148 | Erasca Inc | 39,880 | 544.8K $ | 0.01 % |
| 149 | LENZ Therapeutics Inc | 38,058 | 513.4K $ | 0.01 % |
| 150 | Harmony Biosciences Holdings Inc | 17,525 | 500.2K $ | 0.01 % |
| 151 | Apellis Pharmaceuticals Inc | 23,822 | 499.3K $ | 0.01 % |
| 152 | Tarsus Pharmaceuticals Inc | 4,800 | 362.5K $ | 0.01 % |
| 153 | Keros Therapeutics Inc | 24,578 | 348.8K $ | 0.01 % |
| 154 | BioCryst Pharmaceuticals Inc | 37,881 | 331.5K $ | 0.01 % |
| 155 | Entrada Therapeutics Inc | 14,169 | 169K $ | 0.00 % |
| 156 | Novocure Ltd | 11,113 | 151.9K $ | 0.00 % |
| 157 | BIOXCEL THERAPEUTICS INC | 90,300 | 150.8K $ | 0.00 % |
| 158 | Inhibikase Therapeutics Inc | 56,270 | 115.4K $ | 0.00 % |
| 159 | Ultragenyx Pharmaceutical Inc | 3,489 | 81.6K $ | 0.00 % |
| 160 | OPTINOSE INC | 91,712 | 0.9 $ | |
| 161 | AXCELLA HEALTH INC | 66,454 | 0.7 $ |